Marcio H. Malogolowkin, M.D.
Philosophy of Care
We MUST treat our patients and families as we wish that our own kids and families would be
treated.
Clinical Interests
Pediatric Solid tumors, Developmental Therapeutics Adolescent and Young Adults Cancer.
Research/Academic Interests
Pediatric Solid tumors, Developmental Therapeutics Adolescent and Young Adults Cancer
Title
Professor, Department of Pediatrics
Chief, Division of Hematology Oncology
Specialty
Pediatric Hematology/Oncology
Division
Pediatric Hematology/Oncology
Center/Program Affiliation
UC Davis Children's Hospital
UC Davis Comprehensive Cancer Center
Address/Phone
UC Davis Comprehensive Cancer Center, 2279 45th Street Sacramento, CA 95817
Phone: 916-734-5959
Additional Phone
Phone: 916-734-2781
Clinic Fax: 916-451-3014
Department Referral Phone: 916-734-2782
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Languages
Education
Internships
Portuguese, Spanish
M.D., Federal University of Rio de Janeiro Medical School, Rio de Janeiro, Brazil 1982
Pediatrics Hematology Oncology, Children's Hospital of Los Angeles, Los Angeles CA 1990-1991
Federal University of Rio de Janeiro Medical School, Rio de Janeiro, Brazil 1982
Residency
Fellowships
Board Certifications
Pediatrics, Children's Hospital of Los Angeles, Los Angeles CA 1991-1994
Pediatrics Hematology Oncology, Children's Hospital of Los Angeles, Los Angeles, CA 1986-1989
American Board of Pediatrics, 1998
American Board of Pediatrics, Pediatric Hematology-Oncology, 1998
Professional Memberships
American Society of Clinical Oncology
American Society of Pediatric Hematology/Oncology
Brazilian Society of Pediatric Hematology-Oncology
Marcio H. Malogolowkin, M.D.
Sociedad Latino Americana de Oncologia-Pediatrica
Honors and Awards
Morris & Mary Press Humanism Award, Children's Hospital Los Angeles, 2005
Best Doctors in America, 2008
Top Doctors, Pasadena Magazine, 2010
Super Doctors, Los Angeles Magazine, 2010
Best Doctors in America (r), Milwaukee-Racine-Kenosha Metro Area, 2011
Select Recent Publications
Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L, Effect of
neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma, British Journal of
Surgery 2015 Jan;102(1):108-13.
Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, Kohlmann
W, Curtin K, Fonstad RK, Schiffman JD Congenital abnormalities and hepatoblastoma: A report
from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med
Genet A. 2014 Jun 16;164A(9):220-5.
Gonzalez-Morkos B, Zavala O, Malogolowkin M, Kuperberg A The Teen Impact Experience: A
Webcast Pilot Project for Teens With Cancer and Blood Diseases. J Pediatr Oncol Nurs. 2014 SepOct;31(5):272-6.
Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH,
Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL Surveillance After
Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report
From the Children's Oncology Group. J Clin Oncol. 2014 Feb;10,32(5):465-470.
Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr
Opin Pediatr. 2014 Feb;26(1):19-28.
Marcio H. Malogolowkin, M.D.
Green DM, Breslow NE, D'Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB,
Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PR, Kalapurakal JA
Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor
spill: A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014 Jan;61
(1):134-139.
López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, Leuschner I,
Malogolowkin M, Meyers R, Ranganathan S, Tanaka Y, Tomlinson G, Fabrè M, Zimmermann A,
Finegold MJ Towards an international pediatric liver tumor consensus classification: proceedings of
the Los Angeles COG liver tumors symposium. Mod Pathol. 2014 Mar;27(3):472-491.
Turcotte L, Georgieff M,Ross J, Feusner, J, Tomlinson G, Malogolowkin M, Krailo M, Miller N,
Fonstad R, Spector L Neonatal Medical Exposures and Characteristics of Low Birth Weight
Hepatoblastoma Cases: A Report From the Children’s Oncology Group Pediatr Blood Cancer 2014
Nov;61(11):2018-23.
Czauderna P, Beate H, Hiyama E, Krailo M, Maibach R, Rinaldi E, Aronson D, Malogolowkin M,
Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, Rangaswami A, von
Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R; Children's Hepatic tumors International
Collaboration (CHIC) as a model of international global cooperation and clinical research in
pediatric rare tumors. The Lancet [accepted for publication]2013.
Venkatramani R, Malogolowkin MH, Mascarenhas L Treatment of multiply relapsed wilms tumor
with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr;61
(4):756-759.
© 2016 UC Regents